Will TAVR Replace Low Risk SAVR? (Debate 2)

Debate TAVR Over SAVR in the Management of Young, Low risk Patients - CON - Ismail El-Hamamsy, MDПодробнее

NOTION-2: TAVI vs. SAVR in younger low-risk patients with severe tricuspid/bicuspid aortic stenosisПодробнее

Debate TAVR Over SAVR in the Management of Young, Low risk Patients - PRO - Tarun Chakravaty, MDПодробнее

Challenging Cases and Hallway Conversations: SAVR vs TAVR Decision Making - Part 2Подробнее

Which Low-Risk Patients Should Receive TAVR?Подробнее

The Future of SAVR: The Big DebateПодробнее

Valve-In-Valve TAVR: The End of Redo SAVR? (Steven R. Bailey, MD) April 30, 2016Подробнее

Dr. Robert Bonow discusses TAVR vs SAVR in low risk patientsПодробнее

Short-term data from NOTION-2: TAVR vs SAVI for younger patients with aortic stenosis - EuroPCR 2024Подробнее

SAVR After TAVR Risk CalculatorПодробнее

Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVRПодробнее

TransCatheter Valve Replacement (TAVR) and SAVR-Update on OutcomeПодробнее

TAVR vs. SAVR in Low-Risk Aortic Stenosis - A Comparative Tune of Cardiac Success #cardiologyПодробнее

TCT 2021: PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk PatientsПодробнее

TAVI, SAVR, PCI and low risk patientsПодробнее

2023 Miami Valves: What have I Learned from TAVR ExplantПодробнее

NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valvesПодробнее

Surgeon Q&A: SAVR and TAVR Insights in 2024 with Dr. Joanna ChikweПодробнее